The Current Ratio as of November 2024 (TTM) for Longboard Pharmaceuticals, Inc. (LBPH) is 20.95

According to Longboard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 20.95. This represents a change of 26.58% compared to the average of 16.55 of the last 4 quarters.

Longboard Pharmaceuticals, Inc. (LBPH) Historical Current Ratio (quarterly & annually)

How has LBPH Current Ratio performed in the past?

The mean historical Current Ratio of Longboard Pharmaceuticals, Inc. over the last ten years is 12.67. The current 20.95 Current Ratio has changed 16.44% with respect to the historical average. Over the past ten years (40 quarters), LBPH's Current Ratio was at its highest in in the June 2021 quarter at 36.87. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Longboard Pharmaceuticals, Inc. (LBPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Longboard Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Longboard Pharmaceuticals, Inc. (LBPH) Average Current Ratio

How has LBPH Current Ratio performed in the past?

The current Current Ratio of Longboard Pharmaceuticals, Inc. (LBPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Longboard Pharmaceuticals, Inc. (LBPH) Current Ratio vs. Peers

How is LBPH’s Current Ratio compared to its peers?

Longboard Pharmaceuticals, Inc.’s Current Ratio is greater than Molecular Partners AG (14.58), greater than MediciNova, Inc. (18.24), greater than Anebulo Pharmaceuticals, Inc. (13.46), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), greater than Werewolf Therapeutics, Inc. (12.13), less than Edgewise Therapeutics, Inc. (30.24), greater than Decibel Therapeutics, Inc. (3.03), greater than Celcuity Inc. (14.95), greater than C4 Therapeutics, Inc. (6.31), greater than Assembly Biosciences, Inc. (2.74), greater than NextCure, Inc. (8.35), greater than Nuvation Bio Inc. (11.49), greater than Graphite Bio, Inc. (11.47), greater than Instil Bio, Inc. (15.06), greater than Sensei Biotherapeutics, Inc. (10.90), greater than Merrimack Pharmaceuticals, Inc. (10.78), greater than Monte Rosa Therapeutics, Inc. (6.56), less than Design Therapeutics, Inc. (41.42), greater than Ikena Oncology, Inc. (18.22), greater than Stoke Therapeutics, Inc. (6.67),

Build a custom stock screener for Longboard Pharmaceuticals, Inc. (LBPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longboard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Longboard Pharmaceuticals, Inc. (LBPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Longboard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.